arrow
T

Tzu-Ting Huang

national institutes of health
H指数:27
被引数:1,768

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study

Durvalumab和cediranib联合或不联合olaparib治疗复发性卵巢癌:一项II期概念验证研究

2026-03-160
OAAI
Use of multimedia shared decision-making aids (EATING program) for improving advance care planning engagement among community-dwelling older adults with chronic diseases: A cluster randomized controlled trial

使用多媒体共享决策辅助工具(EATING项目)以提高居住在社区内患有慢性疾病的老年人参与预立医疗照护计划的程度:一项整群随机对照试验

2025-04-010
PRE
Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer model

Regorafenib在小鼠三阴性乳腺癌模型中诱导损伤相关分子模式,癌细胞死亡和免疫调节作用

2023-08-015
OAAI
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCAmutant ovarian cancer
2023-06-2112
OA